eye, with Scer\GAL4GMR.PF
Flies expressing Hsap\INSScer\UAS.cPb under the control of Scer\GAL4GMR.PF exhibit eye defects, including a reduction in eye area, a reduced number of eye bristles, the presence of lesions with no evidence of cells, and the collapse of ommatidial structure and normal array pattern. Black lesions can be present in the eye field where no cellular structure is evident. The phenotype is stronger when two copies of Hsap\INSScer\UAS.cPb are present, and more severe in males than in females. Dosage of Scer\GAL4GMR.PF has no effect on the severity of the phenotype. The phenotype is sensitive to variation in genetic background.
Expression of Hsap\INSC96Y.Scer\UAS in the notum under the control of Scer\GAL4ap-md544 causes a reduction in the posterior margin of the notum and loss of macrochaetae. The phenotype is more severe in males than in females. The phenotype is sensitive to variation in genetic background.
Expression of Hsap\INSC96Y.Scer\UAS in the developing wing imaginal disc causes visible defects in a proportion of adult wings; when expressed under the control of Scer\GAL4dpp.blk1 either the distal margins of wings are scalloped or the anterior crossvein (ACV) is absent, and under the control of Scer\GAL4en-e16E occasional partial loss of the ACV is seen along its posterior boundary. The campaniform sensillae can be absent in portions of the wing where Hsap\INSC96Y.Scer\UAS is expressed: under the control of Scer\GAL4en-e16E the sensillum along the anterior portion of the ACV is typically absent when that portion of the crossvein is missing, and with Scer\GAL4dpp.blk1 three additional sensillae sitting along the distal portion of the longitudinal wing vein 3 can also be absent. Portions of the wing corresponding to Hsap\INSC96Y.Scer\UAS expression are also significantly reduced in area. Expressing Hsap\INSC96Y.Scer\UAS under the control of Scer\GAL4en-e16E results in replacement of the missing ACV sensillae with an ectopic one more anteriorly along the ACV or along the radial wing vein proximal to where it is intersected by the ACV. The posterior crossvein can also project ectopic longitudinal veins.
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has visible | adult stage phenotype, enhanceable by sflGD2336, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has visible | adult stage phenotype, enhanceable by botv510, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has visible | adult stage phenotype, enhanceable by ttvGD1993, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has visible | adult stage phenotype, enhanceable by botvGD2083, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has visible | adult stage phenotype, non-enhanceable by βTub65BGD10881, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has visible | adult stage phenotype, non-enhanceable by ttv00681b, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by sflGD2336, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by botv510, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by ttvGD1993, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has eye phenotype, enhanceable by botvGD2083, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has eye phenotype, non-enhanceable by βTub65BGD10881, Scer\GAL4GMR.PF
Hsap\INSC96Y.UAS, Scer\GAL4GMR.PF has eye phenotype, non-enhanceable by ttv00681b, Scer\GAL4GMR.PF
Expression of sflGD2336 enhances the eye phenotype seen when Hsap\INSC96Y.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF.
Expression of CG32396GD10881 does not enhance the eye phenotype seen when Hsap\INSC96Y.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF.
Expression of ttvGD1993 enhances the eye phenotype seen when Hsap\INSC96Y.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF.
Expression of botvGD2083 enhances the eye phenotype seen when Hsap\INSC96Y.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF.
One copy of ttv00681b does not enhance the eye phenotype seen when Hsap\INSC96Y.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF.
One copy of botv510 enhances the eye phenotype seen when Hsap\INSC96Y.Scer\UAS is expressed under the control of Scer\GAL4GMR.PF.